26S Proteasome p39A Antibodies

Santa Cruz Biotechnology offers a broad range of 26S Proteasome p39A monoclonal antibodies for research in protein degradation and cellular regulation. 26S Proteasome p39A Antibodies are compatible with multiple experimental applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). 26S Proteasome p39A plays a critical role in the ubiquitin-proteasome pathway, which is essential for maintaining cellular homeostasis by regulating protein turnover. 26S Proteasome p39A actively participates in the degradation of misfolded or damaged proteins, preventing the accumulation of potentially toxic aggregates. Research focusing on 26S Proteasome p39A has revealed significant implications for various diseases, including cancer and neurodegenerative disorders. Investigating 26S Proteasome p39A function continues to provide valuable insights into cellular protein regulation mechanisms. Understanding the role of 26S Proteasome p39A advances knowledge about disease development and potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of protein degradation pathways and their impact on human health.